Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cyclerion Therapeutics (CYCN) Assets Average (2019 - 2025)

Cyclerion Therapeutics has reported Assets Average over the past 7 years, most recently at $9.9 million for Q3 2025.

  • Quarterly results put Assets Average at $9.9 million for Q3 2025, up 4.33% from a year ago — trailing twelve months through Sep 2025 was $9.9 million (up 4.33% YoY), and the annual figure for FY2024 was $11.5 million, down 27.04%.
  • Assets Average for Q3 2025 was $9.9 million at Cyclerion Therapeutics, up from $9.6 million in the prior quarter.
  • Over the last five years, Assets Average for CYCN hit a ceiling of $107.7 million in Q1 2021 and a floor of $9.2 million in Q4 2024.
  • Median Assets Average over the past 5 years was $14.3 million (2023), compared with a mean of $31.6 million.
  • Biggest five-year swings in Assets Average: plummeted 73.63% in 2023 and later increased 4.33% in 2025.
  • Cyclerion Therapeutics' Assets Average stood at $63.5 million in 2021, then plummeted by 66.06% to $21.6 million in 2022, then tumbled by 33.72% to $14.3 million in 2023, then tumbled by 35.38% to $9.2 million in 2024, then increased by 7.1% to $9.9 million in 2025.
  • The last three reported values for Assets Average were $9.9 million (Q3 2025), $9.6 million (Q2 2025), and $9.7 million (Q1 2025) per Business Quant data.